KDM1A and cancer: LSD1 inhibitors have been developed (Metzger, et al., 2005; Yang et al., 2018), and demonstrated significant anti-cancer efficacy by inhibiting cancer cell proliferation, differentiation, invasion and migration (Fang et al., 2019).